603998.SH
方盛制药
SSE · Healthcare · Drug Manufacturers - Specialty & Generic · CN
CNY 9.70
−2.32%Margins
Gross margin
73.2%
EBITDA margin
24.7%
EBIT margin
20.2%
Net margin
17.1%
FCF margin
18.7%
17.7%
Return on equity
10.0%
Return on assets
17.2%
Return on invested capital
0.59x
Asset turnover
CNY 442.9M
Cash from operations
—
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Mar 1, 2026